An obvious point: investing is a numbers game. There are so many options to choose from and nobody wants to miss out on a big winner (aka stock FOMO). You can play it safe with a total stock market Vanguard option and ride the average of all American companies. Or try the opposite extreme by picking a single full-conviction winner and wait patiently through ups-and-downs for that big growth jump.
To help ease stomach churning you might want to invest somewhere in the middle with a small sample size portfolio containing low cap/high growth potential companies and allow individual fluctuations to even themselves out as they will rise/fall at different time periods. The overall goal of course is to, on average, make positive ground daily as well as throughout the years cumulatively. So grab your rig and start loading up the trailer!
15 Long-Haulers:
Jounce Therapeutics (JNCE) $362M
Puma Biotechnology (PBYI) $458M
Altimmune (ALT) $552M
Brightcove (BCOV) $573M
Perion (PERI) $574M
HEXO (HEXO) $972M
Vaxart (VXRT) $1.1B
PubMatic (PUBM) $1.6B
Viant Technology (DSP) $1.7B
Rubius Therapeutics (RUBY) $2.5B
LiveRamp (RAMP) $2.9B
Magnite (MGNI) $4.2B
Digital Turbine (APPS) $6.9B
First Solar (FSLR) $8.4B
The Trade Desk (TTD) $28.6B
“Not all those who wander are lost.” –J.R.R. Tolkien